Ultrasound-Guided Central Venous Access: Internal Jugular Vein

Veins can be distinguished from arteries by their compressibility - veins easily collapse when pressure is applied, while arteries maintain their shape. When identifying a vessel, briefly compressing it reveals whether it is a vein (collapses) or an artery (remains round). This distinction is critical because accidentally puncturing an artery can cause significant complications.

Arteries and veins can be distinguished using Doppler ultrasound through multiple criteria: on grayscale, arteries pulsate with thick, non-compressible walls while veins are non-pulsatile with thin, easily compressible walls; on color Doppler, arteries typically show positive (toward transducer) flow above the baseline while veins show negative (away from transducer) flow below the baseline, though exceptions exist like the portal vein; and on spectral Doppler, arteries display pulsatile waveforms with triphasic, biphasic, or monophasic patterns depending on resistance level, whereas normal veins show spontaneous, non-pulsatile, phasic flow with augmentation and compressibility, with five key features including spontaneous flow, non-pulsatility, phasicity, augmentability, and compressibility.

Veins have very thin walls, are easily compressable, appear black or anechoic inside, and have non-pulsatile flow. Arteries have thicker walls, are pulsatile, and are not as easily compressable. Use color Doppler to distinguish between them: blue indicates flow away from the probe, red indicates flow toward the probe. The key is to look for pulsatility to identify arteries.

Ultrasound is a mechanical longitudinal wave with frequencies above 20,000 Hz that propagates through tissue, where frequency determines penetration depth (low frequency penetrates deeper but with less resolution, while high frequency provides better resolution but shallower imaging), and image quality depends on proper probe selection (curved/array for deep structures, linear for superficial structures), depth adjustment, gain control, and understanding transducer orientation where the probe marker indicates the patient's head/right side and the near field appears at the top of the screen.

Differentiating arteries from veins using ultrasound is fundamental to safe vascular procedures. Arteries are thick-walled, pulsatile, and non-compressible, while veins are thin-walled, non-pulsatile, and easily compressible under probe pressure. For equipment setup, high-frequency linear transducers provide optimal resolution for superficial vessels despite reduced penetration depth. Infection control follows AAMI guidelines requiring probe covers plus low-level disinfection, with sterile sleeves preferred over Tegaderm due to regulatory considerations and probe protection concerns.

Central venous access is indicated when peripheral access is unavailable, for specific medications (vasopressors like norepinephrine and epinephrine), high-flow requirements (dialysis, plasma exchange), or hemodynamic monitoring. Contraindications include thrombocytopenia (<50,000 platelets), prolonged thrombin time (>3 seconds), local infection, and unilateral lung disease. Site selection is individualized based on complication risks, operator skill, and patient factors. Jugular is preferred for beginners due to compressibility and easier learning curve. Subclavian has the lowest infection rate but higher pneumothorax risk (1.5% vs 0.5% for jugular) and is contraindicated in coagulopathy or hyperinflated lungs. Femoral allows immediate use without X-ray but has higher infection and thrombosis risks. For cardiac arrest, femoral is preferred for immediate use. For tracheostomized patients, subclavian avoids infection risk. For chronic renal disease, avoid subclavian to preserve dialysis fistula options.

Peripheral IV access is suitable for most medications including analgesia and antibiotics, typically placed in the hand or antecubital fossa, but central venous access is required for vasoactive drugs like adrenaline, parenteral nutrition, or when peripheral veins are damaged or insufficient; central lines deliver medication directly to the superior vena cava for more reliable and rapid distribution.

Central venous access involves catheter tip placement in large deep veins (jugular, subclavian, femoral, iliofemoral). Indications include incompatible peripheral access, extracorporeal therapies, hemodynamic monitoring, and endovascular device placement. Contraindications are relative (proximity to lesions, infection, coagulopathy). Right-sided access is preferred to avoid thoracic duct injury. The Seldinger technique (wire-guided) is standard. Ultrasound guidance is essential for vessel identification (veins collapse with pressure). Sites: jugular (triangle apex, 35-45° angle), subclavian (2 cm lateral/inferior to clavicle), femoral (1 cm medial/inferior to inguinal ligament).

Central venous access is indicated when: (1) Peripheral access fails, (2) Vasopressor therapy is needed, (3) Hemodynamic monitoring is required, (4) Parenteral nutrition is needed, (5) High-concentration medications require administration, (6) Hemodialysis is needed, (7) Pacing leads or cardiac catheterization are required. Complications include pneumothorax (reduced with ultrasound guidance), infection, hematoma, and thrombosis. Site selection depends on patient factors: femoral access has lower mechanical complications but higher infection risk, while subclavian access has lower infection risk but higher pneumothorax risk. For patients with unilateral lung pathology, the contralateral side should be avoided.

Central venous catheter access is indicated for blood specimen collection, medication and fluid administration, long-term infusion therapy when peripheral access is unavailable, vesicant/hyperosmolar infusions, complex infusion therapies, and checking catheter patency. Contraindications include suspected thrombus or infection (manifesting as excess fluid/discharge at insertion site) and catheter fracture/disruption. Essential equipment includes 3mL and 10mL syringes (larger for flushing/blood return, smaller for blood collection), saline flush, blood specimen containers, antiseptic wipes, 2x2 gauze, gloves, and hand sanitizer. The procedure requires explaining to the patient, hand hygiene with antiseptic sanitizer or soap/water, and gathering equipment before beginning.

The CLABSI bundle includes: (1) Daily assessment of central line necessity with prompt removal, (2) Daily physician review of line necessity, (3) Skin antisepsis using appropriate antiseptic, (4) Comprehensive coverage of all hub connections with sterile single-use caps, (5) Hand hygiene and full surgical PPE before access, (6) Maintaining sterile field during insertion, (7) Changing transparent dressings every 5-7 days or sooner if wet or loose, (8) Changing gauze dressings every 2 days or sooner if wet or loose.

The central line bundle is a standardized set of five evidence-based practices—hand hygiene with surgical scrub, chlorhexidine gluconate skin antisepsis, proper site selection (subclavian vein preferred), maximum sterile barrier technique, and daily line review—that must be followed together to prevent central line-associated bloodstream infections; all central lines must be placed by a qualified inserter and observed by an independent qualified observer (bedside nurse) who certifies the procedure, and lines not certified must be removed within 24 hours.

CLABSI is defined as line-confirmed bacterial infection with central line in place for more than 2 days. Prevention requires: maximal barrier precautions (cap, mask, gown, gloves, drape) for insertion, alcohol-based skin antisepsis (preferred over chlorhexidine for preterms <35 weeks), dedicated team approach, limiting ports to 4 and port accesses to 2 per day, hub scrubbing, and empowering nurses to remove lines. CLABSI bundle approach can reduce rates by 60%. There is no role for routine antimicrobial dressings or prophylactic antibiotics.

To prevent central line-associated bloodstream infections (CLABSIs), healthcare providers must follow five evidence-based best practices: (1) remove unnecessary central lines, (2) perform hand hygiene before and during line placement and maintenance, (3) use maximal barrier precautions including sterile gown, gloves, cap, mask, and large sterile drape covering the patient, (4) use chlorhexidine as the preferred antiseptic for skin antisepsis, and (5) avoid femoral vein insertion sites due to higher infection and thrombotic complication rates; additional maintenance practices include cleaning catheter hubs with alcohol or chlorhexidine-alcohol combinations before access, changing transparent dressings every 5 days or sooner if loose/damp, and replacing administration sets not used for blood products or lipids every 96 hours.

CLABSI is a laboratory-confirmed bloodstream infection occurring after 48 hours of central line placement or within 24 hours of removal. Prevention requires both insertion and maintenance bundles. Insertion bundle components include hand hygiene, optimal site selection (subclavian/jugular preferred over femoral), maximal barrier precautions (sterile gown, gloves, cap, full-body drape), chlorhexidine 2% skin antisepsis, and appropriate catheter sizing. Maintenance involves daily assessment of necessity, hub scrubbing before access, dedicated lumens for TPN/blood, and strict adherence to aseptic technique as the most effective prevention strategy.